[1] Devarbhavi H, Asrani SK, Arab JP, et al. Global burden of liver disease: 2023 update. J Hepatol, 2023. 79(2): 516-537.
[2] Llopis M, Cassard AM, Wrzosek L, et al. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut, 2016. 65(5):830-839.
[3] Lang S, Schnabl B, Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future. Cell Host Microbe, 2020, 28(2): 233-244.
[4] Lowe PP, Gyongyosi B, Satishchandran A, et al. Reduced gut microbiome protects from alcohol-induced neuroinflammation and alters intestinal and brain inflammasome expression. J Neuroinflammation, 2018. 15(1): 298.
[5] Chen P, Stärkel P, Turner JR, et al.Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology, 2015. 61(3): 883-894.
[6] Inamine T, Yang AM, Wang L, et al. Genetic Loss of Immunoglobulin A Does Not Influence Development of Alcoholic Steatohepatitis in Mice. Alcohol Clin Exp Res, 2016. 40(12): 2604-2613.
[7] Gu M, Samuelson DR, Taylor CM, et al. Alcohol-associated intestinal dysbiosis alters mucosal-associated invariant T-cell phenotype and function. Alcohol Clin Exp Res, 2021. 45(5): 934-947.
[8] Riva A, Patel V, Kurioka A, et al. Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease. Gut, 2018. 67(5): 918-930.
[9] Hendrikx T, Duan Y, Wang Y, et al. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice. Gut, 2019. 68(8): 1504-1515.
[10] Yue R, Wei X, Zhao J, et al. Essential Role of IFN-gamma in Regulating Gut Antimicrobial Peptides and Microbiota to Protect Against Alcohol-Induced Bacterial Translocation and Hepatic Inflammation in Mice. Front Physiol, 2020,11: 629141.
[11] Hao L, Zhong W, Woo J, et al. Conventional type 1 dendritic cells protect against gut barrier disruption via maintaining Akkermansia muciniphila in alcoholic steatohepatitis. Hepatology, 2023. 78(3):096-910.
[12] Grander C, Adolph TE, Wieser V, et al. Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut, 2018. 67(5): 891-901.
[13] Hartmann P, Seebauer CT, Schnabl B. Alcoholic liver disease: the gut microbiome and liver cross talk. Alcohol Clin Exp Res, 2015. 39(5): 763-775.
[14] An L, Wirth U, Koch D, et al. The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases. J Gastrointest Surg, 2022. 26(3): 671-683.
[15] Jia L, Chang X, Qian S, et al. Hepatocyte toll-like receptor 4 deficiency protects against alcohol-induced fatty liver disease. Mol Metab, 2018. 14: 121-129.
[16] Saikia P, Roychowdhury S, Bellos D, et al. Hyaluronic acid 35 normalizes TLR4 signaling in Kupffer cells from ethanol-fed rats via regulation of microRNA291b and its target Tollip. Sci Rep, 2017. 7(1): 15671.
[17] Zhou H, Yu M, Roychowdhury S, et al. Myeloid-MyD88 Contributes to Ethanol-Induced Liver Injury in Mice Linking Hepatocellular Death to Inflammation. Alcohol Clin Exp Res, 2017. 41(4): 719-726.
[18] Duan Y, Chu H, Brandl K, et al. CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease. Nat Commun, 2021. 12(1): 7172.
[19] Gao B, Emami A, Nath S, et al. Microbial Products and Metabolites Contributing to Alcohol-Related Liver Disease. Mol Nutr Food Res, 2021. 65(5): e2000023.
[20] Zhou R, Llorente C, Cao J, et al. Deficiency of Intestinal alpha1-2-Fucosylation Exacerbates Ethanol-Induced Liver Disease in Mice. Alcohol Clin Exp Res, 2020. 44(9):1842-1851.
[21] Zhou R, Llorente C, Cao J, et al. Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in Mice. Cell Mol Gastroenterol Hepatol, 2021. 12(1): 293-320.
[22] Singhal R, Donde H, Ghare S, et al. Decrease in acetyl-CoA pathway utilizing butyrate-producing bacteria is a key pathogenic feature of alcohol-induced functional gut microbial dysbiosis and development of liver disease in mice. Gut Microbes, 2021. 13(1): 1946367.
[23] Donde H, Ghare S, Joshi-Barve S, et al. Tributyrin Inhibits Ethanol-Induced Epigenetic Repression of CPT-1A and Attenuates Hepatic Steatosis and Injury. Cell Mol Gastroenterol Hepatol, 2020. 9(4): 569-585.
[24] Chen P, Torralba M, Tan J, et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology, 2015. 148(1): 203-214 e16.
[25] Warner J, Hardesty J, Song Y, et al. Fat-1 Transgenic Mice With Augmented n3-Polyunsaturated Fatty Acids Are Protected From Liver Injury Caused by Acute-On-Chronic Ethanol Administration. Front Pharmacol, 2021. 12: 711590.
[26] Hartmann P, Hochrath K, Horvath A, et al. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice. Hepatology, 2018. 67(6):2150-2166.
[27] Spatz M, Ciocan D, Merlen G, et al. Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis. JHEP Rep, 2021. 3(2): 100230.
[28] Matye DJ, Li Y, Chen C, et al. Gut-restricted apical sodium-dependent bile acid transporter inhibitor attenuates alcohol-induced liver steatosis and injury in mice. Alcohol Clin Exp Res, 2021. 45(6): 1188-1199.
[29] Zhang M, Kong B, Huang M, et al. FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice. Dig Liver Dis, 2018. 50(10): 1068-1075.
[30] Huang M, Kong B, Zhang M, et al. Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency. Lab Invest, 2020. 100(9): 1158-1168.
[31] Wu WB, Chen YY, Zhu B, et al. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice. Biochimie, 2015. 115: 86-92.
[32] Gao B, Duan Y, Lang S, et al. Functional Microbiomics Reveals Alterations of the Gut Microbiome and Host Co-Metabolism in Patients With Alcoholic Hepatitis. Hepatol Commun, 2020. 4(8): 1168-1182.
[33] Gu Z, Li F, Liu Y, et al. Exosome-Like Nanoparticles From Lactobacillus rhamnosusGG Protect Against Alcohol-Associated Liver Disease Through Intestinal Aryl Hydrocarbon Receptor in Mice. Hepatol Commun, 2021. 5(5): 846-864.
[34] Qian M, Liu J, Zhao D, et al. Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver Disease. Cell Mol Gastroenterol Hepatol, 2022. 13(1): 233-256. |
